Pfizer earns positive Phase 3 in multiple myeloma; ICON overstated revenue

April 29, 2026 11:28 AM EDT News Briefing Pfiz­er earns pos­i­tive Phase 3 in mul­ti­ple myelo­ma; ICON over­stat­ed rev­enue ENDPOINTS Pfiz­er’s pos­i­tive Phase 3 da­ta in mul­ti­ple myelo­ma: The com­pa­ny’s El­rex­fio pro­duced a “sta­tis­ti­cal­ly sig­nif­i­cant and clin­i­cal­ly mean­ing­ful im­prove­ment” in pro­gres­sion-free … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER